- 69301. viral haemorrhagic septicemia virus
- [ ] (UMLS (CSP) C0318853) =Virus
| - 69351. virus development
- [ ] (UMLS (CSP) C0599615) =Organism Function
|
- 69302. VIRAL HEP CARRIER NOS
- (UMLS (ICD9CM) C0549126) =Finding
| - 69352. virus DNA
- [DNA that makes up the genetic material of viruses. ( CSP )] (UMLS (CSP) C0012939) =Nucleic Acid, Nucleoside, or Nucleotide =deoxyribonucleic acid;
nucleocapsid |
- 69303. Viral hepatitis
- (UMLS (ICPC) C0042721) (Viral hepatitis; HEPATITIS ZOLDURAGARRIA; Virus hepatit; Virus hepatitis; VIRUSHEPATIITTI; Hepatite virale; akute Virushepatitis; tzahevet medabeket (A,B,C); virus hepatitis; Epatite virale; INFEKSIOS HEPATITT; Hepatite viral; Hepatitis infecciosa; VIRUSHEPATIT) =Disease or Syndrome ;
=Body System, Gastrointestinal; Diagnosis/Diseases Component | - 69353. virus entry
- [The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by translocation of the whole virus across the cell membrane. ( MSH )] (UMLS (CSP) C1537068) =Biologic Function ;
|
- 69304. Viral hepatitis B with hepatic coma
- [ ] (UMLS (ICD9CM) C0153076) =Disease or Syndrome
| - 69354. virus host interaction
- [Interactions, directly with the host cell macromolecular machinery, to allow virus replication. [ISBN:0781718325] ( GO )] (UMLS (CSP) C0599952) =Cell Function
|
- 69305. Viral hepatitis B without mention of hepatic coma
- (UMLS (ICD9CM) C0700211) =Disease or Syndrome
| - 69355. virus identification
- [ ] (UMLS (CSP) C0599616) =Laboratory Procedure
|
- 69306. Viral Laryngitis
- (UMLS (NCI) C0853195) =Disease or Syndrome
| - 69356. virus inactivation
- [Inactivation of viruses by non-immune related techniques. They include extremes of pH, HEAT treatment, ultraviolet radiation, IONIZING RADIATION; DESICCATION; ANTISEPTICS; DISINFECTANTS; organic solvents, and DETERGENTS. ( MSH )] (UMLS (CSP) C0599953) =Laboratory Procedure
|
- 69307. viral latency
- [The ability of a pathogenic virus to lie dormant within a cell (latent infection). In eukaryotes, subsequent activation and viral replication is thought to be caused by extracellular stimulation of cellular transcription factors. Latency in bacteriophage is maintained by the expression of virally encoded repressors. ( MSH )] (UMLS (CSP) C0206188) =Organism Function
| - 69357. virus infection mechanism
- [multi-step process by which a virus binds to, enters, and replicates within a host cell; includes both surface and intracellular interactions between host and virus. ( CSP )] (UMLS (CSP) C0597653) =Organism Attribute =virus characteristic;
=virus cytopathogenic effect;
virus multiplication;
virus integration;
virus virus interaction;
|
- 69308. viral leukemia
- [leukemia (progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow) for which a virus is the etiological agent. ( CSP )] (UMLS (CSP) C0597646) =Neoplastic Process ;
=Blood (Leukemia);
virus related neoplasm/cancer =hairy cell leukemia;
acute T cell leukemia;
Friend leukemia | - 69358. virus integration
- [naturally occurring process of insertion of viral DNA into the host genome; not a genetic technique. ( CSP )] (UMLS (CSP) C0085224) =Biologic Function =virus infection mechanism;
|
- 69309. viral leukemogenesis
- [process by which normal cells are transformed into leukemia by means of a virus. ( CSP )] (UMLS (CSP) C0597647) =Neoplastic Process ;
=viral carcinogenesis;
| - 69359. virus load
- [measure of the concentration of a virus in the blood or other body fluids; used as a measure of the severity of a virus infection. ( CSP )] (UMLS (CSP) C1261478) =Laboratory Procedure ;
=Infection, Viral;
|
- 69310. viral leukoencephalitis
- [ ] (UMLS (CSP) C0599610) =Disease or Syndrome ;
| - 69360. virus morphology
- [form and structure of viruses. ( CSP )] (UMLS (CSP) C0597654) =Organism Attribute =virus characteristic;
=nucleocapsid;
coat (enveloped virus);
|
- 69311. Viral Load
- [The number of viral particles (usually HIV) in a sample of blood plasma. ( NCI )] (UMLS (NCI) C0376705) =Finding
| - 69361. virus multiplication
- [process of forming progeny virus from input virus; involves expression and replication of viral genomic nucleic acid and the assembly of progeny virus particles. ( CSP )] (UMLS (CSP) C0042774) =Organism Function =virus infection mechanism;
=provirus;
virus assembly;
|
- 69312. viral myelinopathy
- [any virus disease of the myelin; degeneration of the white matter of the brain of viral etiology. ( CSP )] (UMLS (CSP) C0597648) =Disease or Syndrome ;
=Infection, Viral;
myelinopathy;
nervous system infection;
=Leukoencephalopathy, Progressive Multifocal;
Dawson's encephalitis;
| - 69362. virus pathogenesis
- [ ] (UMLS (CSP) C0920672) =Cell or Molecular Dysfunction ;
|
- 69313. viral neoplasm
- [ ] (UMLS (CSP) C0872301) virus related neoplasm =Neoplastic Process ;
| - 69363. virus registry
- [ ] (UMLS (CSP) C1328966) =Manufactured Object; Intellectual Product
|
- 69314. Viral Oncogene
- [Cancer-causing genes encoded in viral genomes. Usually denoted v-onc. ( NCI )] (UMLS (NCI) C1336966) =Gene or Genome
| - 69364. Virus Related Cancer
- [This category currently includes only malignancies in which there is a well documented association between the neoplastic process and a specific virus as a causative agent.--2003 ( NCI )] (UMLS (NCI) C0920673) Virus Related Malignancy;
Virus-Related Cancer;
Virus-Related Malignancy;
Virus-Related Malignant Neoplasm =Neoplastic Process ;
|
- 69315. Viral Oncogene Protein
- [Proteins expressed by virally mutated genes that once played a normal role in the cell as a proto-oncogene. There are several different types of viral oncogene proteins, and the expression of these proteins contributes to a transformed phenotype in cells. ( NCI )] (UMLS (NCI) C0029015) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 69365. Virus Related Carcinoma
- (UMLS (NCI) C1336967) Virus-Related Carcinoma =Neoplastic Process
|
- 69316. Viral Phenotype Susceptibility
- (UMLS (HL7) C1698491) =Laboratory Procedure =Susceptibility Testing;
| - 69366. virus related diabetes mellitus
- [diabetes mellitus that is caused or exacerbated by the presence of a virus in the body. ( CSP )] (UMLS (CSP) C0597655) =Disease or Syndrome =Diabete mellito;
Infection, Viral |
- 69317. Viral Protein
- [proteins found in any species of virus. ( CSP )] (UMLS (NCI) C0042736) =Amino Acid, Peptide, or Protein; Biologically Active Substance =gene product;
=GAG Protein;
integrase;
HIV envelope protein | - 69367. Virus Related Lymphoma
- (UMLS (NCI) C1336968) Virus-Related Lymphoma =Neoplastic Process
|
- 69318. Viral Receptor
- [viruses must first bind to their target cell's surface before infection can proceed; this is mediated by specific molecular receptors for certain viral antigens, many of which have other known functions; e.g., the MHC-II receptor CD4 is also an HIV receptor. ( CSP )] (UMLS (NCI) C0034848) =Amino Acid, Peptide, or Protein; Receptor =Cell Surface Receptor;
| - 69368. virus related neoplasm/cancer
- [human or animal neoplasms or cancers that are caused or exacerbated by the presence of a virus in the body. ( CSP )] (UMLS (CSP) C0597656) =Neoplastic Process =Infection, Viral;
infection related neoplasm/cancer =rabbit papilloma;
GARATXAK;
avian leukosis/sarcoma;
Lucke renal adenocarcinoma;
viral leukemia |
- 69319. viral rescue
- [the reactivation of a defective virus either by recombination or by complementation of the defective functions. ( CSP )] (UMLS (CSP) C0597649) =Organism Attribute =virus characteristic;
| - 69369. virus resource
- [ ] (UMLS (CSP) C1328967) =Manufactured Object; Intellectual Product
|
- 69320. Viral Respiratory Tract Infection
- (UMLS (NCI) C0877203) =Disease or Syndrome
| - 69370. virus RNA
- [RNA that makes up the genetic material of viruses. ( CSP )] (UMLS (CSP) C0035736) =Nucleic Acid, Nucleoside, or Nucleotide =Ribonucleic acid;
nucleocapsid |
- 69321. Viral Transport medium
- (UMLS (HL7) C1550094) =Biomedical or Dental Material ;
=Additive/Preservative;
| - 69371. virus seed resource
- [ ] (UMLS (CSP) C1328968) =Manufactured Object; Intellectual Product
|
- 69322. Viral Transport medium
- [Sucrose 74.6g, Potassium hydrogenphosphate 0.52g, L-glutamic acid 0.72g, Bovine serum albumin 5.0g, Gentamicin 50mg, Potassium dihydrogenphosphate 1.25g, L-15 medium 9.9L, Water to 10L. Maintain Virus viability. ( HL7V3.0 )] (UMLS (HL7) C1556115) =Intellectual Product =MaterialEntityAdditive;
| - 69372. virus tropism
- [ ] (UMLS (CSP) C0599954) =Organism Attribute
|
- 69323. viral vaccine
- [suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. ( CSP )] (UMLS (CSP) C0042742) =Pharmacologic Substance; Immunologic Factor =[IM100] VACCINES;
=flu vaccine;
measles;
poliomyelitis vaccine;
RABIES VACCINE;
smallpox;
hepatitis vaccine;
AIDS vaccine;
Herpesviridae vaccine;
paramyxovirus vaccine;
Pneumovirus vaccine;
rotavirus vaccine | - 69373. virus unmasking
- [ ] (UMLS (CSP) C0599612) =Organism Attribute
|
- 69324. viral vector development
- [ ] (UMLS (CSP) C0872302) =Biomedical Occupation or Discipline ;
| - 69374. virus virus interaction
- [refers to various types of interactions that can occur between two or more viruses. ( CSP )] (UMLS (CSP) C0597657) =Organism Function =virus infection mechanism;
|
- 69325. VIRAL WARTS NOS
- (UMLS (ICD9CM) C0343642) =Disease or Syndrome
| - 69375. Virus-like Particle
- [A complex of the retrotransposon RNA genome, reverse transcriptase, integrase, and associated molecules required for reproduction and integration of the retrotransposon into the host genome; the main structural molecule of the nucleocapsid is often a gag protein homolog. [GOC:clt, PMID:10861903] ( GO )] (UMLS (NCI) C1325725) VLP;
=Cell Component ;
|
- 69326. Viramide
- (UMLS (NCI) C0702029) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 69376. Virus-Related Sarcoma
- (UMLS (NCI) C1336969) =Neoplastic Process
|
- 69327. Viramune
- (UMLS (NCI) C0728726) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 69377. Visa
- (UMLS (HL7) C1549055) =Organization =Organization, agency, department;
|
- 69328. virilism
- [abnormal possession of mature masculine somatic characteristics by a girl, woman, or prepubescent; may be present at birth or may appear first later in life, depending on its cause; it may be relatively mild (hirsutism) or severe; commonly the result of gonadal or adrenocortical dysfunction, or may be produced by androgenic therapy. ( CSP )] (UMLS (CSP) C0042755) =Sign or Symptom ;
=adrenal disorder;
gonad disorder;
sex development disorder;
=hirsutism | - 69378. VISA
- (UMLS (HL7) C1549756) =Idea or Concept =Identifier type;
|
- 69329. Virilon
- (UMLS (NCI) C0724290) Virilon brand of testosterone 17 beta-cypionate =Steroid; Pharmacologic Substance; Hormone
| - 69379. Visa
- (UMLS (HL7) C1554978) =Idea or Concept =CreditCard;
|
- 69330. virion
- [the infectious unit of a virus. ( CSP )] (UMLS (CSP) C0042760) =Cell Component =virus characteristic;
| - 69380. viscera
- [The soft internal organs of the body, including the lungs, the heart, and the organs of the digestive, excretory, and reproductive systems. ( NCI )] (UMLS (NCI) C0042779) =Body Part, Organ, or Organ Component
|
- 69331. viroid
- [A group of pathogens comprising the smallest known agents of infectious disease. They are unencapsulated and are capable of replicating autonomously in susceptible cells. Positively identified viroids composed of single-stranded RNA have been isolated from higher plants, but the existence of DNA viroids pathogenic to animals is suspected. ( MSH )] (UMLS (CSP) C0042761) =Virus =microorganism;
=prion | - 69381. visceral
- [Having to do with the viscera, which are the soft internal organs of the body, including the lungs, the heart, and the organs of the digestive, excretory, reproductive, and circulatory systems. ( NCI )] (UMLS (NCI) C0442045) =Spatial Concept
|
- 69332. virology
- [ ] (UMLS (CSP) C0042762) =Biomedical Occupation or Discipline
| - 69382. visceral afferent nerve
- [sensory nerve bringing impulses from the viscera toward the central nervous system. ( CSP )] (UMLS (CSP) C0597658) =Body Part, Organ, or Organ Component =afferent nerve;
|
- 69333. Virology
- (UMLS (HL7) C1548007) =Intellectual Product =Diagnostic Service Section ID;
| - 69383. Visceral Layer of Bowman's Capsule
- (UMLS (NCI) C0227644) =Body Part, Organ, or Organ Component
|
- 69334. Virorax
- (UMLS (NCI) C0920749) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 69384. Visceral Pleura
- [The layer investing the lungs and dipping into the fissures between the several lobes. ( NCI )] (UMLS (NCI) C0225776) =Body Part, Organ, or Organ Component
|
- 69335. Virormone
- (UMLS (NCI) C0592254) =Steroid; Pharmacologic Substance ;
| - 69385. Visceral Surface of the Liver
- (UMLS (NCI) C0458927) =Body Location or Region
|
- 69336. Virosome
- [Virosomes are reconstituted influenza virus (A/Singapore) envelopes. The membrane of these vesicles consists of a spherical, unilamellar lipid bilayer. Purified influenza envelope glycoproteins (hemagglutinin HA and neuramindase NA) are inserted into the lipid bilayer. Virosomes with a bilayer consisting of neutral phospholipids can be used as an unspecific or a specific drug carrier system, while positively charged vesicles can be used as a transfer system for any genetic materials. ( NCI )] (UMLS (NCI) C0887910) Virosomes =Amino Acid, Peptide, or Protein; Lipid
| - 69386. viscoelasticity
- [ ] (UMLS (CSP) C0599618) =Quantitative Concept
|
- 69337. virtual
- [A patient encounter where the patient and the practitioner(s) are not in the same physical location. Examples include telephone conference, email exchange, robotic surgery, and televideo conference. ( HL7V3.0 )] (UMLS (HL7) C1553497) =Intellectual Product =ActEncounterCode;
| - 69387. viscosity
- [physical property of fluids that determines the internal resistance to flow. ( CSP )] (UMLS (CSP) C0042784) =Natural Phenomenon or Process =Physical Phenomenon;
=body fluid viscosity |
- 69338. virtual reality
- [An artificial environment generated by a computer that simulates the actual (real) world. Users can control VR programs through sensory loaded gloves and headsets, that are equipped with video monitors that give feeling of movement through 3-dimensional "virtual" environments. ( NCI )] (UMLS (CSP) C0871582) =Machine Activity ;
| - 69388. Viscotoxin
- [A member of a group of small proteins produced by mistletoe plants that are able to kill cells and may stimulate the immune system. ( NCI )] (UMLS (NCI) C1314790) =Amino Acid, Peptide, or Protein; Hazardous or Poisonous Substance ;
|
- 69339. Virtual table query
- (UMLS (HL7) C1548128) =Idea or Concept =Message type;
| - 69389. Visible
- [Perceptible especially by the eye; open to easy view. ( NCI )] (UMLS (NCI) C0205379) =Qualitative Concept
|
- 69340. Virudox
- (UMLS (NCI) C0731020) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 69390. VISIBLE PERISTALSIS
- [ ] (UMLS (ICD9CM) C0159059) =Finding
|
- 69341. virulence
- [degree of pathogenicity of a microorganism as indicated by the severity of the disease produced and its ability to invade the tissues of a host; the competence of any infectious agent to produce pathologic effects. ( CSP )] (UMLS (NCI) C0042765) =Biologic Function =Microbiology;
| - 69391. visible spectrometry
- [ ] (UMLS (CSP) C0598195) =Laboratory Procedure
|
- 69342. Virulizin
- [A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents. ( NCI )] (UMLS (NCI) C0254455) =Pharmacologic Substance; Immunologic Factor ;
| - 69392. Visilizumab
- [A monoclonal antibody that binds to CD3 (a substance found on T-cells) and that is being studied as a treatment for graft-versus-host disease (GVHD). It belongs to the family of drugs called monoclonal antibodies. ( NCI )] (UMLS (NCI) C1134691) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 69343. virus
- [group of minute infectious agents characterized by a lack of independent metabolism and by the ability to replicate only within living host cells; have capsid, may have DNA or RNA (not both). ( CSP )] (UMLS (NCI) C0042776) =Virus =microorganism;
=bacterial virus;
DNA virus;
RNA virus | - 69393. vision aid
- [device or technology to assist sight; for other techniques used to aid the visually disabled, see BLIND AID. ( CSP )] (UMLS (CSP) C0441068) =Medical Device =communication disorder aid;
eye prosthesis =contact lens;
|
- 69344. virus antigen
- [substances elaborated by viruses that have antigenic activity. ( CSP )] (UMLS (CSP) C0003342) =Immunologic Factor
| - 69394. vision disorder
- [visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision; may result from eye diseases, optic nerve diseases, visual pathway diseases, occipital lobe diseases, ocular motility disorders, etc; visual disability refers to inability of the individual to perform specific visual tasks, such as reading, writing, orientation, or traveling unaided. ( CSP )] (UMLS (CSP) C0042790) =Disease or Syndrome =communication disorder;
Disorder of eye, unspecified;
Sensation Disorders;
sensory disorder =amblyopia;
night blindness;
scotoma;
color blindness;
blindness;
congenital vision disorder;
amblyopia;
Color Vision Defects;
diplopia;
night blindness;
scotoma;
DISTURBANCES OF VISION;
photophobia;
blindness;
|
- 69345. virus assembly
- [coming together of the constituent parts of a virus particle; process can vary from autoassembly of protein subunits around the viral nucleic acid to assembly of complex viruses at cell membranes. ( CSP )] (UMLS (CSP) C0282629) =Biologic Function ;
=virus multiplication;
| - 69395. vision dispense invoice
- [Vision dispense invoice for up to 2 lens (left and right), frame and optional discount. Eye exams are invoiced as a clinical service invoice. ( HL7V3.0 )] (UMLS (HL7) C1555659) =Intellectual Product =ActInvoiceRootGroupCode;
|
- 69346. virus characteristic
- [features that helps to identify, distinguish or describe recognizably; classification systems of viruses; includes infection routes, staining patterns, replication requirements, etc. ( CSP )] (UMLS (CSP) C0597650) =Organism Attribute =Microbiology;
=defective virus;
helper virus;
hepatitis virus;
insect virus;
oncogenic virus;
plant virus;
interfering virus;
virion;
simian virus;
neurotropic virus;
noncytopathogenic virus;
respiratory virus;
transforming virus;
viral rescue;
virus infection mechanism;
virus morphology;
prophage | - 69396. Vision impaired
- [Vision impaired ( HL7V3.0 )] (UMLS (HL7) C1550443) =Idea or Concept =PersonDisabilityType;
|
- 69347. virus classification
- [used for taxonomic or other systematic or hierarchical virus classification systems. ( CSP )] (UMLS (CSP) C0597651) =Intellectual Product =microorganism classification;
| - 69397. vision test
- [diagnostic test of visual function. ( CSP )] (UMLS (CSP) C0042793) =Diagnostic Procedure =eye disorder diagnosis;
=perimetry;
flicker fusion test;
|
- 69348. virus core
- [ ] (UMLS (CSP) C0598995) =Nucleic Acid, Nucleoside, or Nucleotide; Amino Acid, Peptide, or Protein
| - 69398. Vision Therapy
- (UMLS (HL7) C1555955) =Intellectual Product =Optometrist;
|
- 69349. virus culture
- [ ] (UMLS (CSP) C0200955) =Laboratory Procedure
| - 69399. Visit
- [The act of going to see some person or place or thing; it can cover a short or long period but refers to a non-permanent arrangement. ( NCI )] (UMLS (NCI) C0545082) =Behavior
|
- 69350. virus cytopathogenic effect
- [visible morphologic changes in virus-infected cells effecting intracellular structures and cell functions, e.g. chromosomal aberrations, viral inclusion bodies, membrane permeability, and protein synthesis; do not confuse with CELL TRANSFORMATION. ( CSP )] (UMLS (CSP) C0010827) =Cell or Molecular Dysfunction ;
=virus infection mechanism;
| - 69400. Visit Indicator
- (UMLS (HL7) C1547721) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Account level (default);
Visit level |
home 
Armenian-English 
top